Back to the drug test guide

K2 or Spice Test Evidence

Has Caused a False Positive

Lamotrigine

Source Kurku et al., Scand J Clin Lab Invest 2021

What It Found

  • Urine from lamotrigine users showed a K2/1 signal despite negative targeted LC-MS/MS.
  • Adding lamotrigine or user urine reproduced the interference.

Keep in Mind

  • This assay targets synthetic cannabinoid metabolites such as those of JWH-018.
  • Its findings do not establish interference on a conventional marijuana test.

Test Studied

  • K2/1 synthetic cannabinoid metabolite homogeneous enzyme immunoassay

A Related Drug the Test Picks Up

JWH-122

Source Kronstrand et al., Anal Bioanal Chem 2014

What It Found

  • The assay recognized metabolites of JWH-122 while it failed to recognize the tested UR-144 metabolites.

Keep in Mind

  • This dedicated synthetic-cannabinoid test differs from a routine THC screen.
  • The named metabolites and antibody target matter.

Test Studied

  • Synthetic-cannabinoid urine immunoassay with LC-QTOF-MS confirmation

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The antibody recognized JWH-122 or specific metabolites in the urine challenge table.
  • For JWH-018 and JWH-073 the hydroxylation position markedly affected the response.

Keep in Mind

  • Specific antibodies and the actual metabolite determine the result.
  • This assay is distinct from conventional urine THC testing.

Test Studied

  • NMS synthetic-cannabinoid JWH-018 N-(5-hydroxypentyl) metabolite ELISA

MAM-2201

Source Kronstrand et al., Anal Bioanal Chem 2014

What It Found

  • The assay recognized metabolites of MAM-2201 while it failed to recognize the tested UR-144 metabolites.

Keep in Mind

  • This dedicated synthetic-cannabinoid test differs from a routine THC screen.
  • The named metabolites and antibody target matter.

Test Studied

  • Synthetic-cannabinoid urine immunoassay with LC-QTOF-MS confirmation

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The antibody recognized MAM-2201 or specific metabolites in the urine challenge table.
  • For JWH-018 and JWH-073 the hydroxylation position markedly affected the response.

Keep in Mind

  • Specific antibodies and the actual metabolite determine the result.
  • This assay is distinct from conventional urine THC testing.

Test Studied

  • NMS synthetic-cannabinoid JWH-018 N-(5-hydroxypentyl) metabolite ELISA

AM-1220

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The antibody recognized AM-1220 or specific metabolites in the urine challenge table.
  • For JWH-018 and JWH-073 the hydroxylation position markedly affected the response.

Keep in Mind

  • Specific antibodies and the actual metabolite determine the result.
  • This assay is distinct from conventional urine THC testing.

Test Studied

  • NMS synthetic-cannabinoid JWH-018 N-(5-hydroxypentyl) metabolite ELISA

AM-2201

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The antibody recognized AM-2201 or specific metabolites in the urine challenge table.
  • For JWH-018 and JWH-073 the hydroxylation position markedly affected the response.

Keep in Mind

  • Specific antibodies and the actual metabolite determine the result.
  • This assay is distinct from conventional urine THC testing.

Test Studied

  • NMS synthetic-cannabinoid JWH-018 N-(5-hydroxypentyl) metabolite ELISA

JWH-018

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The antibody recognized JWH-018 or specific metabolites in the urine challenge table.
  • For JWH-018 and JWH-073 the hydroxylation position markedly affected the response.

Keep in Mind

  • Specific antibodies and the actual metabolite determine the result.
  • This assay is distinct from conventional urine THC testing.

Test Studied

  • NMS synthetic-cannabinoid JWH-018 N-(5-hydroxypentyl) metabolite ELISA

JWH-019

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The antibody recognized JWH-019 or specific metabolites in the urine challenge table.
  • For JWH-018 and JWH-073 the hydroxylation position markedly affected the response.

Keep in Mind

  • Specific antibodies and the actual metabolite determine the result.
  • This assay is distinct from conventional urine THC testing.

Test Studied

  • NMS synthetic-cannabinoid JWH-018 N-(5-hydroxypentyl) metabolite ELISA

JWH-073

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The antibody recognized JWH-073 or specific metabolites in the urine challenge table.
  • For JWH-018 and JWH-073 the hydroxylation position markedly affected the response.

Keep in Mind

  • Specific antibodies and the actual metabolite determine the result.
  • This assay is distinct from conventional urine THC testing.

Test Studied

  • NMS synthetic-cannabinoid JWH-018 N-(5-hydroxypentyl) metabolite ELISA

JWH-200

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The antibody recognized JWH-200 or specific metabolites in the urine challenge table.
  • For JWH-018 and JWH-073 the hydroxylation position markedly affected the response.

Keep in Mind

  • Specific antibodies and the actual metabolite determine the result.
  • This assay is distinct from conventional urine THC testing.

Test Studied

  • NMS synthetic-cannabinoid JWH-018 N-(5-hydroxypentyl) metabolite ELISA

JWH-398

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The antibody recognized JWH-398 or specific metabolites in the urine challenge table.
  • For JWH-018 and JWH-073 the hydroxylation position markedly affected the response.

Keep in Mind

  • Specific antibodies and the actual metabolite determine the result.
  • This assay is distinct from conventional urine THC testing.

Test Studied

  • NMS synthetic-cannabinoid JWH-018 N-(5-hydroxypentyl) metabolite ELISA

The Test Is Made to Find It

UR-144

Source Kronstrand et al., Anal Bioanal Chem 2014

What It Found

  • The assay did not recognize the tested metabolites of UR-144, a synthetic cannabinoid.

Test Studied

  • A synthetic-cannabinoid urine immunoassay compared with LC-QTOF-MS

Source Mohr et al., J Anal Toxicol 2014

What It Found

  • This dedicated assay recognized hydroxylated UR-144 and XLR-11 metabolites more strongly than the parent drugs.
  • Parent-drug cross-reactivity was below 10%.

Keep in Mind

  • This describes the intended test and targets.
  • It does not imply a positive standard THC screen.

Test Studied

  • Urine ELISA designed specifically to detect UR-144 and XLR-11, compared with LC-MS/MS

2 sources Mohr et al., J Anal Toxicol 2014 Barnes et al., Ther Drug Monit 2015

What It Found

  • The NMS antibody showed negligible or absent recognition of the tested UR-144 material, in contrast to a test designed specifically to identify UR-144/XLR-11.

2 sources Kronstrand et al., Anal Bioanal Chem 2014 Mohr et al., J Anal Toxicol 2014

Keep in Mind

  • Other specific synthetic-cannabinoid assays can be designed to recognize UR-144 metabolites.

All 3 sources Kronstrand et al., Anal Bioanal Chem 2014 Mohr et al., J Anal Toxicol 2014 Barnes et al., Ther Drug Monit 2015

Keep in Mind

  • The compounds are genuine synthetic cannabinoids, but screening tests cover different structures.

Source Barnes et al., Ther Drug Monit 2015

Test Studied

  • NMS synthetic-cannabinoid JWH-018 metabolite ELISA

XLR-11

Source Mohr et al., J Anal Toxicol 2014

What It Found

  • This dedicated assay recognized hydroxylated UR-144 and XLR-11 metabolites more strongly than the parent drugs.
  • Parent-drug cross-reactivity was below 10%.

Keep in Mind

  • This describes the intended test and targets.
  • It does not imply a positive standard THC screen.

Test Studied

  • Urine ELISA designed specifically to detect UR-144 and XLR-11, compared with LC-MS/MS

Both sources Mohr et al., J Anal Toxicol 2014 Barnes et al., Ther Drug Monit 2015

What It Found

  • The NMS antibody showed negligible or absent recognition of the tested XLR-11 material, in contrast to a test designed specifically to identify UR-144/XLR-11.

Keep in Mind

  • The compounds are genuine synthetic cannabinoids, but screening tests cover different structures.

Source Barnes et al., Ther Drug Monit 2015

Test Studied

  • NMS synthetic-cannabinoid JWH-018 metabolite ELISA

Suspected, but Not Proven

Buprenorphine

Source Barnes et al., Forensic Sci Int 2014

What It Found

  • A mixture of buprenorphine and norbuprenorphine, each at 1,000 ng/mL, gave a K2 Spice response of 7.3 ng/mL.
  • That crossed the investigators’ proposed 5 ng/mL cutoff but stayed below the manufacturer’s 10 ng/mL cutoff.

Keep in Mind

  • The first experiment cannot tell whether buprenorphine itself, its metabolite, or their combination accounted for the signal.

Test Studied

  • Immunalysis K2 Spice urine homogeneous enzyme immunoassay

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • On the separate NMS ELISA, challenges including both compounds at 1,000 ng/mL did not produce a positive or appreciably suppress the 5 ng/mL control.

Test Studied

  • NMS urine ELISA targeting a JWH-018 metabolite

Both sources Barnes et al., Forensic Sci Int 2014 Barnes et al., Ther Drug Monit 2015

Keep in Mind

  • Neither study establishes a positive screening result after someone takes buprenorphine.
  • The findings concern dedicated synthetic-cannabinoid screens.

Tested: No False Positive Found

2C-B

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with 2C-B.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

6-Acetylcodeine

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with 6-acetylcodeine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Acetaminophen

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with acetaminophen.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Alprazolam

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with alprazolam.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Amphetamine

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with amphetamine and p-hydroxyamphetamine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • The paper identifies the standard as amphetamine without specifying an isomer or testing a marketed formulation.
  • It also tested the named hydroxy metabolite.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Aspirin

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with acetylsalicylic acid.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

BDB

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with BDB.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Bromazepam

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with bromazepam.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Brompheniramine

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with brompheniramine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Caffeine

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with caffeine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Cannabidiol

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with cannabidiol.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Cannabigerol

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with cannabigerol.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Cannabinol

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with cannabinol.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Cathinone

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with cathinone.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Chlorpheniramine

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with chlorpheniramine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Clomipramine

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with clomipramine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Clonazepam

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with clonazepam and 7-aminoclonazepam.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Clonidine

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with clonidine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Cocaethylene

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with cocaethylene and norcocaethylene.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Cocaine (medical topical use)

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with cocaine, benzoylecgonine, norcocaine, ecgonine, norbenzoylecgonine, ecgonine ethyl ester, ecgonine methyl ester, anhydroecgonine methyl ester and the tested hydroxylated metabolites.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • These were chemical standards.
  • The study did not test urine following topical medical cocaine administration.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Codeine

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with codeine and norcodeine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Dextromethorphan

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with dextromethorphan.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Diazepam

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with diazepam and nordiazepam.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Diphenhydramine

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with diphenhydramine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Dronabinol

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with THC, 11-hydroxy-THC and THC-COOH.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • The study used THC and its metabolites as chemical standards.
  • It did not test urine collected after dronabinol dosing.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Ephedrine

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with ephedrine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Ethylamphetamine

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with ethylamphetamine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Flunitrazepam

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with flunitrazepam and 7-aminoflunitrazepam.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Fluoxetine

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with fluoxetine and norfluoxetine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Flurazepam

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with flurazepam.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Heroin

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with 6-acetylmorphine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Only the heroin metabolite 6-acetylmorphine (6-MAM) was tested.
  • The experiment gives no direct result for the parent drug.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Hydrocodone

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with hydrocodone.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Ibuprofen

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with ibuprofen.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Imipramine

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with imipramine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Ketamine

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with ketamine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Lorazepam

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with lorazepam.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

MBDB

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with MBDB.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

MDA

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with MDA.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

MDEA

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with MDEA.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

MDMA

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with MDMA and its HMA and HMMA derivatives.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Methadone

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with methadone, EDDP and EMDP.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Methamphetamine

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with methamphetamine and p-hydroxymethamphetamine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Morphine

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with morphine, normorphine and morphine-3- and morphine-6-glucuronide.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Nicotine replacement therapy

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with nicotine, cotinine, norcotinine and trans-3′-hydroxycotinine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • These were chemical standards.
  • The study did not test urine after use of a nicotine patch, gum or other replacement product.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Nitrazepam

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with nitrazepam and 7-aminonitrazepam.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Oxazepam

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with oxazepam.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Oxycodone

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with oxycodone and noroxycodone.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Oxymorphone

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with oxymorphone and noroxymorphone.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Paroxetine

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with paroxetine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Pentazocine

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with pentazocine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Phentermine

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with phentermine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

PMA

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with p-methoxyamphetamine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

PMMA

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with p-methoxymethamphetamine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Propoxyphene

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with propoxyphene.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Pseudoephedrine

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with pseudoephedrine.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite

Temazepam

Source Barnes et al., Ther Drug Monit 2015

What It Found

  • The researchers challenged the assay with temazepam.
  • At 1,000 ng/mL each, the listed challenges did not produce a positive test or appreciably suppress the control at 5 ng/mL.

Keep in Mind

  • Laboratory challenge on this dedicated synthetic-cannabinoid assay.
  • The study did not test the effects of taking a commercial formulation or establish performance on conventional THC screens.

Test Studied

  • NMS urine ELISA calibrated to the JWH-018 N-(5-hydroxypentyl) metabolite